Combined with previous studies, we believe that the promotion of miR-424-5p on NSCLC growth and DDP resistance is achieved by modulating SOCS5, SOCS6 JAK2/STAT3, and PI3K/AKT pathways. The gene discussed is JAK2; the disease is non-small cell lung carcinoma.